January 100 club winners: Julia Gower, Tony Ball, Beryl Slater Well Done
Posts By: Sue
Stem cell study: positive results for relapsing remitting MS
Source MS Society: Treating people with relapsing remitting MS with stem cell transplantation therapy might help prevent relapses and prevent disability progression, according to a smallclinical trial carried out in the US. Read on
Happy New Year
Happy New Year from Sue, The Committee and the Therapists, Please note that Membership for the current year is now due and is £25 and there is also a slight increase in recommended donations on therapies apart from oxygen, please see noticeboard. An update on Mark Walker: As some of you are aware Mark was taken ill… Read more »
The Royal College of Physicians want the opinions of patients with long-term problems
I would like to let you know about a new project the Royal College of Physicians Health Informatics Unit is leading on improving patient care records for people with long term conditions. The project is part of a European project to develop electronic health record which are accessible and a benefit to patients. The RCP… Read more »
How many elves – winner!
The winner of the ‘how many elves’ was Helen Thorpe, there were 162. Helen won a lovely Hamper full of Asda goodies. Thanks to Emma from Asda who organised and donated the hamper.
100 Club Winners for December
100 club winners for December – Geoff Fewings, Roger Nicholls, Ismay Ratliff, well done.
Christmas closure
Centre Closure over Christmas/New Year The Centre is open, on: Tues 23rd for oxygen, footcare and reiki. Tues 30th for oxygen Wed 31st for osteopathy Friday 2nd January for oxygen and Massage Resuming normal hours on Monday 5th January Wishing you all a very Merry Christmas, from Sue and everyone at the Centre
Fingolimod (Gilenya) not effective in primary progressive MS
Source MS Society: “Note – While these results are disappointing, they do not affect the proven effectiveness of Gilenya in relapsing remitting MS.” Novartis – the pharmaceutical company that manufacture Gilenya – carried out a global phase 3 clinical trial involving 940 people with primary progressive MS, known as INFORMS. The trial aimed to evaluate… Read more »
Bone mineral density is reduced in people with MS
Source MSRA.org: Evidence has been accumulating over recent years that people with MS are at increased risk of osteoporosis and bone fractures in comparison to the general population. Osteoporosis is a progressive loss of bone minerals leading to fragile bones that are at greater risk of fracturing. It is common in the ageing population and… Read more »
Thank you!
Thank you to everyone who has given up their time to collect at a supermarket during the year, the grand total for the year is £2387.42. Many thanks indeed. I hope you along with some new members will be able to help collect during 2015.
